Loading organizations...
§ Private Profile · Shenzhen, Guangdong, China
Biotechnology company focused on viral therapies and treatments.
Immvira has raised $68.0M across 2 funding rounds.
Immvira has raised $68.0M in total across 2 funding rounds.
Immvira has raised $68.0M across 2 funding rounds. Most recently, it raised $10.0M Series B in September 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 24, 2020 | $10M Series B | Shanghai Healthcare Capital | — | Announced |
| Jun 15, 2020 | $58M Series B | Huagai Capital | Apricot Capital | Announced |
Immvira has raised $68.0M in total across 2 funding rounds.
Immvira's investors include Shanghai Healthcare Capital, Huagai Capital, Apricot Capital.